Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Chromatin immunoprecipitation (ChIP) Sequencing Market Expected To Grow In Terms Of Size?
The size of the chromatin immunoprecipitation (chip) sequencing market has seen a quick expansion in recent times. The market is projected to rise from a valuation of $13.89 billion in 2024 to $15.48 billion in 2025, representing a compound annual growth rate (CAGR) of 11.4%. Factors like enhanced comprehension of gene regulation, an increase in studies related to epigenetics, utilization of data analysis, bioinformatics tools as well as cost reduction and scalability have contributed to the historic growth of this market.
Anticipated to witness a surge in the forthcoming years, the Chromatin immunoprecipitation (chip) sequencing market is expected to magnify to a substantial $25.3 billion in 2029, with a compound annual growth rate (CAGR) of 13.1%. The predicted growth in this period is mainly due to the industry investment and competition, rapid adoption in clinical and diagnostic applications, increasing demand for biomarker discovery, swift advancements in bioinformatics tools, and extended usage in drug discovery. The key trends during this forecast period encompass the clinical translation and diagnostic applications, heightened focus on histone modifications, novel research areas applications, advancements in preparing samples, and integration of multi-omics.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp
What Are The Primary Factors Supporting The Chromatin immunoprecipitation (ChIP) Sequencing Market Expansion?
The growth of the chromatin immunoprecipitation (ChIP) sequencing market is predicted to be boosted due to the rising occurrence of prostate cancer. This type of cancer, which originates in the prostate gland – a small, walnut-sized gland in males that aids in semen production, plays a key role in prostate cancer research. ChIP-seq provides a holistic insight into the molecular incidents stimulating the disease, facilitating important knowledge that contributes to a refined comprehension of its biology. This, in turn, paves the way for the creation of more precise and effective treatment approaches. For example, data from the American Cancer Society, a US-based organization battling cancer, indicated that in January 2023, the US had an estimated 288,300 new cases of prostate cancer and 34,700 deaths resulting from it. Consequently, the escalating incidence of prostate cancer is influencing the growth of the chromatin immunoprecipitation (ChIP) sequencing market.
Which Segmentation Categories Are Highlighted In The Chromatin immunoprecipitation (ChIP) Sequencing Market Analysis?
The chromatin immunoprecipitation (chip) sequencingmarket covered in this report is segmented –
1) By Type: DNase-Sequencing; FAIRE-Sequencing
2) By Technology: Targeted Sequencing And Re-Sequencing; Whole Genome Sequencing And Whole Exome Sequencing
3) By Workflow: Pre-Sequencing; Sequencing; Data Analysis
4) By Application: Consumables And Reagents; Service; Other Applications
5) By End-User: Academic Research Institutes; Clinical Research Institutes; Hospitals And Clinics; Pharmaceuticals And Biotechnology Companies; Other End Users
Subsegments:
1) By DNase-Sequencing: DNase I Hypersensitivity Mapping; DNase-Seq For Open Chromatin Regions
2) By FAIRE-Sequencing: Formaldehyde-Assisted Isolation Of Regulatory Elements (FAIRE); FAIRE-Seq For Active Regulatory Regions
Which Notable Trends Are Transforming The Chromatin immunoprecipitation (ChIP) Sequencing Market Outlook?
Leading businesses in the chromatin immunoprecipitation (ChIP) sequencing market are concentrating on the development of novel technologies such as hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing) to improve the efficacy and precision of epigenomic research, propelling progress in tailored medication and drug discovery. hmqChIP-seq is a cutting-edge technology designed to bolster the examination of epigenetic changes across the genome. For example, Epigenica, a biotechnology company based in Sweden, launched the EpiFinder Platform in June 2024 which incorporates their patented hmqChIP-seq technology. This allows high-throughput, quantitative multiplexing in epigenomic research. This revolutionary platform empowers researchers to create 192 genome-wide profiles concurrently from a maximum of 24 samples, simplifying extensive experiments with remarkable speed and affordability.
Which Organizations Are At The Forefront Of The Chromatin immunoprecipitation (ChIP) Sequencing Market?
Major companies operating in the chromatin immunoprecipitation (chip) sequencing market report are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam PLC, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies PLC, Porvair Sciences Ltd., Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Chromatin immunoprecipitation (ChIP) Sequencing Market?
North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13265&type=smp
Browse Through More Reports Similar to the Global Chromatin immunoprecipitation (ChIP) Sequencing Market 2025, By The Business Research Company
Clinical Oncology Next Generation Sequencing Global Market Report 2025
Ngs Based Rna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Prenatal Dna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model